Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2022-05-02 00:00:00 ET · period of report 2022-04-28 · accession 0000902664-22-002740 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-05-02 | 2022-04-28+ | LAB | JOHNSON DAVID EDWARD | 10% | P - Purchase | $2.69 | +400.0K | 9.36M | +4% | +$1.08M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-02 | P | A | 125,000 | $2.81 | 9,484,838 | I See footnote | — | — | (F4) Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $ 2.71 to $2.89. (F5) The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. (F2) The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. |
| 2 | Common | Common Stock, $0.001 par value per share ("Common Stock") | 2022-04-28 | P | A | 27,600 | $2.40 | 9,112,438 | I See footnote | — | — | (F1) Price is the volume weighted average selling price of all sales by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $2.37 to $2.44. (F5) The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. (F2) The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. |
| 3 | Common | Common Stock | 2022-04-29 | P | A | 247,400 | $2.66 | 9,359,838 | I See footnote | — | — | (F3) Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $2.57 to $2.70. (F5) The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price. (F2) The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. |